Literature DB >> 22061040

Characterization of alpha-amino-n-butyric acid correlations in sepsis.

Carlo Chiarla1, Ivo Giovannini, John H Siegel.   

Abstract

Little information is available on the patterns of changes and significance of plasma alpha-amino-n-butyric acid (ABA, μmol/L) in various conditions, particularly in sepsis. This study has been performed to assess the patterns of correlation among ABA, other amino acids, and other variables in a group of septic patients with various degrees of illness. More than 400 determinations of ABA, other amino acids, and simultaneously collected blood variables were obtained in 17 patients with sepsis. The distribution of ABA was characterized by the clustering of most measurements within the normal range (<41 μmol/L), with the spreading of abnormally increased values up to 151 μmol/L. Abnormal increases in ABA were related directly to alanine, serine, tyrosine, histidine, proline, threonine, glycine, glutamine, cysteine, lysine, cystathionine, leucine, valine, phenylalanine, arginine, and citrulline (r(2) from 0.86 to 0.32) and related inversely to aspartate, taurine, and phosphoethanolamine (r(2) from 0.62 to 0.50) (P < 0.001 for all). Furthermore, increased ABA was correlated with increasing total aminoacidemia, lactate, neutrophil concentration, creatinine, ammonia, osmolarity, glucose, and bilirubin and with decreasing AA Fischer ratio and peripheral O(2) extraction (r(2) from 0.87 to 0.16) (P < 0.001 for all). High ABA was also associated with low cholesterol, taurine, and platelet count, and with high 3-methylhistidine (partly anticipating the increase), high blood urea nitrogen, and pulmonary shunt (P < 0.001 for all). Finally, high ABA was related to the worsening of sepsis-related organ failure assessment score (SOFA score) and of most plasma AA clearances (P < 0.001 for all). Abnormally increased ABA may signal and partly anticipate the transition to an extreme derangement of septic metabolic patterns, characterized by the worsening of protein hypercatabolism with hyperaminoacidemia and by signs of impaired hepatic amino acid metabolism and oxidative metabolism. Increased ABA may represent an additional landmark of transition to extreme illness, compelling the need for the aggressive resolution of sepsis. Copyright Â
© 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22061040     DOI: 10.1016/j.trsl.2011.06.005

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  12 in total

1.  Gaussian and linear deconvolution of LC-MS/MS chromatograms of the eight aminobutyric acid isomers.

Authors:  Harika Vemula; Yukiko Kitase; Navid J Ayon; Lynda Bonewald; William G Gutheil
Journal:  Anal Biochem       Date:  2016-10-19       Impact factor: 3.365

2.  A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.

Authors:  H Blasco; C Veyrat-Durebex; M Bertrand; F Patin; F Labarthe; H Henique; P Emond; C R Andres; C Antar; C Landon; L Nadal-Desbarats; F Maillot
Journal:  JIMD Rep       Date:  2016-06-15

3.  Hyperphenylalaninemia Correlated with Global Decrease of Antioxidant Genes Expression in White Blood Cells of Adult Patients with Phenylketonuria.

Authors:  Charlotte Veyrat-Durebex; Christelle Debeissat; Hélène Blasco; Franck Patin; Hélène Henique; Patrick Emond; Catherine Antar; Valérie Gissot; Olivier Herault; François Maillot
Journal:  JIMD Rep       Date:  2017-03-15

4.  Polymorphisms of cystathionine beta-synthase gene are associated with susceptibility to sepsis.

Authors:  Christoph Sponholz; Marcel Kramer; Franziska Schöneweck; Uwe Menzel; Kolsoum Inanloo Rahatloo; Evangelos J Giamarellos-Bourboulis; Vassileios Papavassileiou; Korina Lymberopoulou; Maria Pavlaki; Ioannis Koutelidakis; Ioannis Perdios; André Scherag; Michael Bauer; Matthias Platzer; Klaus Huse
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

5.  Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumors.

Authors:  Nobuyoshi Hiraoka; Sakino Toue; Chisato Okamoto; Shinya Kikuchi; Yoshinori Ino; Rie Yamazaki-Itoh; Minoru Esaki; Satoshi Nara; Yoji Kishi; Akira Imaizumi; Nobukazu Ono; Kazuaki Shimada
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

6.  Serum metabolite markers of early Mycoplasma hyopneumoniae infection in pigs.

Authors:  Meera Surendran Nair; Dan Yao; Chi Chen; Maria Pieters
Journal:  Vet Res       Date:  2019-11-26       Impact factor: 3.683

7.  Charged metabolite biomarkers of food intake assessed via plasma metabolomics in a population-based observational study in Japan.

Authors:  Eriko Shibutami; Ryota Ishii; Sei Harada; Ayako Kurihara; Kazuyo Kuwabara; Suzuka Kato; Miho Iida; Miki Akiyama; Daisuke Sugiyama; Akiyoshi Hirayama; Asako Sato; Kaori Amano; Masahiro Sugimoto; Tomoyoshi Soga; Masaru Tomita; Toru Takebayashi
Journal:  PLoS One       Date:  2021-02-10       Impact factor: 3.240

8.  Severe Spinal Cord Injury in Rats Induces Chronic Changes in the Spinal Cord and Cerebral Cortex Metabolism, Adjusted by Thiamine That Improves Locomotor Performance.

Authors:  Alexandra Boyko; Polina Tsepkova; Vasily Aleshin; Artem Artiukhov; Garik Mkrtchyan; Alexander Ksenofontov; Lyudmila Baratova; Sergey Ryabov; Anastasia Graf; Victoria Bunik
Journal:  Front Mol Neurosci       Date:  2021-03-29       Impact factor: 5.639

9.  Quantification of aminobutyric acids and their clinical applications as biomarkers for osteoporosis.

Authors:  Zhiying Wang; Liangqiao Bian; Chenglin Mo; Hui Shen; Lan Juan Zhao; Kuan-Jui Su; Maciej Kukula; Jauh Tzuoh Lee; Daniel W Armstrong; Robert Recker; Joan Lappe; Lynda F Bonewald; Hong-Wen Deng; Marco Brotto
Journal:  Commun Biol       Date:  2020-01-22

10.  The serum amino acid profile in COVID-19.

Authors:  Alptug Atila; Handan Alay; Mehmet Emrah Yaman; Tugrul Cagri Akman; Elif Cadirci; Burak Bayrak; Saffet Celik; Nihal Efe Atila; Aycan Mutlu Yaganoglu; Yucel Kadioglu; Zekai Halıcı; Emine Parlak; Zafer Bayraktutan
Journal:  Amino Acids       Date:  2021-10-04       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.